Lipid-lowering medication use and cancer-specific survival among endometrial or lung cancer patients: an Australian nationwide cohort study.
Jia-Li FengXiwen QinPublished in: European journal of clinical pharmacology (2020)
Among LLM users, adherence to this drug is inversely associated with reduced cancer-specific mortality. Together with previous evidence, randomised controlled trials are called for to confirm whether LLMs could be considered as an adjuvant treatment to improve prognosis.
Keyphrases
- papillary thyroid
- end stage renal disease
- squamous cell
- chronic kidney disease
- ejection fraction
- newly diagnosed
- peritoneal dialysis
- prognostic factors
- emergency department
- lymph node metastasis
- childhood cancer
- adipose tissue
- fatty acid
- skeletal muscle
- patient reported outcomes
- adverse drug
- drug induced
- free survival
- patient reported